Navigation Links
Chimpanzees can transmit cultural behavior to multiple 'generations'

sion of behavior and traditions.

For more than seven decades, the Yerkes National Primate Research Center of Emory University has been dedicated to advancing scientific understanding of primate biology, behavior, veterinary care and conservation, and to improving human health and well-being. Today, the center, as one of only eight National Institutes of Health-funded national primate research centers, provides specialized scientific resources, expertise and training opportunities. Recognized as a multidisciplinary research institute, the Yerkes Research Center is making landmark discoveries in the fields of microbiology and immunology, neuroscience, psychobiology and sensory-motor systems. Research programs are seeking ways to: develop vaccines for AIDS and malaria; treat cocaine addiction; interpret brain activity through imaging; increase understanding of progressive illnesses such as Parkinson's and Alzheimers; unlock the secrets of memory; determine behavioral effects of hormone replacement therapy; address vision disorders; and advance knowledge about the evolutionary links between biology and behavior.


'"/>

Source:Emory University Health Sciences Center


Page: 1 2 3

Related biology news :

1. Chimpanzees found to use tools to hunt mammalian prey
2. Female sex hormones play a vital role in defense against sexually transmitted diseases
3. Researchers make surprise discovery that some neurons can transmit three signals at once
4. Two new retroviruses—transmitted from animals—identified
5. New study: Sexually transmitted disease treatment can be effectively administered by sex partners
6. High rates of sexually transmitted infections found in young drug users
7. Neurotransmitters signal aggressive cancer, offer potential for early diagnosis
8. Teens unaware of sexually transmitted diseases until they catch one, Carnegie Mellon study finds
9. Blood transfusion-transmitted infections: A global perspective
10. Study shows enzyme builds neurotransmitters via newly discovered pathway
11. Low levels of neurotransmitter serotonin may perpetuate child abuse across generations
Post Your Comments:
(Date:12/14/2009)... support of the United Nations Framework Convention on ... Environment Agency hosted the ,Bend the Trend, event ... networking platform and premiere the screening of the ... Atlas of Europe, a joint project of the ... (UNEP) and ESA, is a series of short ...
(Date:12/13/2009)... Haven, Conn.A team led by Yale University researchers ... whole blood for the first time. Their findings, ... publication of Nature Nanotechnology , could dramatically ... cancer and other diseases. , The ... of Engineering & Applied Science, and Tarek Fahmy, ...
(Date:12/11/2009)... species of wild apples that could be an ancestor ... and Central Asia. A new study comparing the diversity ... Georgia and Armenia with previously collected varieties originating in ... a core collection that will make M. orientalis ... , To identify and record the genetic diversity of ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Understanding apples' ancestors 2Safety and Quality Contribute to Popularity of Assisted Living 48888 1Safety and Quality Contribute to Popularity of Assisted Living 48888 2Cynvec to Present at The 2009 New York Venture Summit 12624 1Cynvec to Present at The 2009 New York Venture Summit 12624 2The downside of microtubule stability 8825 1
... Cell Metabolism has provided insight into a key mechanism ... a novel approach to the development of cholesterol-lowering drugs ... the most prescribed cholesterol inhibitors, according to researchers at ... obtain cholesterol, an important component of cell membranes, by ...
... University of Washington Alaska Salmon Program, the world's longest-running ... nearly $2.4 million from the Gordon and Betty Moore ... The Alaska-based program has applications for Pacific salmon all ... fortunes of salmon runs and their management. , The ...
... The oyster mushroom (Pleurotus ostreatus), apart from reducing cholesterol ... for breaking down cellulose. Finding out which genes are ... is sometimes used as a decontaminating agent, was the ... which she defended at the Public University of Navarre ...
Other Biology News:Insight into natural cholesterol control suggests novel cholesterol-lowering therapy 2Alaskan puzzles, monitoring provide insight about North Pacific salmon runs 2Advances in the characterisation of the oyster mushroom genes 2
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces that ... in its catalogue: ,, The ... Forecasts to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, ... "The Future of Orphan Diseases Therapeutics - ...
(Date:12/15/2009)... Dec. 15 The Mosaic Company (NYSE: ... year 2010 earnings results and financial tables on Tuesday, ... the New York Stock Exchange. Results will be ... The Company will host a conference call with presentation ... results. The call will begin at 11:00 a.m. ...
(Date:12/15/2009)... Dec. 15 Thomson ... ® has become the first drug pipeline database ... outcome information. This highly anticipated new content is ... month. ,, Thomson Pharma ... registries, publications, press releases, conferences, and other sources ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4
... With Patented Triple Arterial Lumen ... ... Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP) today announced that ... the 2008,Society of Interventional Radiology (SIR) Annual Scientific Meeting to be,held ...
... Trubion Pharmaceuticals,Inc. (Nasdaq: TRBN ) today announced financial ... as well as 2008 financial guidance., Fourth Quarter and ... of 2007 was $5.7 million compared with,$6.4 million for the ... 2007, was $20.1 million compared with $36.5 million for the ...
... 1:30 p.m. (Pacific Time); ... http://www.adventrx.com , SAN DIEGO, March 13 ... focused on in-licensing,developing and commercializing proprietary product candidates primarily ... financial,results for the fourth quarter and year ended December ...
Other Biology Technology:Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 2Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 3Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 4Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 5Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 2Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 3Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 4Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 5Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 2ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 3ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 4ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 5ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 7
... FLISP Assay with FAM-Labeled Substrate (green ... Accurately measure serine protease activation • ... B-Bridge's FLISP Kits utilize cell-permeable, fluorescently ... to measure chymotrypsin-like activity in whole ...
Request Info...
... provides the firm pressure necessary to ... tubes or plates. The multifunctional tool ... firmly holds thin-wall 0.5 ml tubes ... or closing. A side slot allows ...
... The Gene Pulser Xcell microbial system, ... is used for electroporation of bacterial ... the main unit, PC module for ... 10 sterile cuvettes (5 each of ...
Biology Products: